Skip to content

The Effect of Continuous Infusion of Nitroglycerin and dobutamine on occult hypoperfusion in patients under anesthesia

Evaluation of continuous infusion of Nitroglycerin and Dobutamine on incidence and severity of Occult Hypoperfusion in Orthopedic Surgery’s Patients who underwent General and Epidural Anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011815774N2
Enrollment
56
Registered
2015-04-04
Start date
2013-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic acidosis. An abnormal increase in the acidity of the body's fluids

Interventions

Intervention 1: Treatments in intervention group included trinitroglycerin 0.1 µg/kg/min and dobutamine 1.5-2 µg/kg/min during surgery. Intervention 2: The control group received 100 cc normal saline
Treatment - Drugs
Treatments in intervention group included trinitroglycerin 0.1 µg/kg/min and dobutamine 1.5-2 µg/kg/min during surgery
The control group received 100 cc normal saline as placebo during the surgery

Sponsors

Vice chancellor for research, Iran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: inclusion criteria : Patient's satisfaction with participating in the study; Patients with group I and II ASA Score; No history of Liver or Renal insufficiency, DM, HTN, Heart and Pulmonary disease; No acid-base disorders; No TNG, dubotamine or anesthetic drugs allergy; No emergent surgery; No pregnancy; No contraindications of TNG(Idiopathic hypertrophic subaortic stenosis, post myocardial infarction hypertension); No contraindications of dubotamine( myocardial infarction, open angle glaucoma, allergy to phosphodiesterase inhibitors, cerebral hemorrhage, ICP rise, severe anemia, orthostatic hypotention, sildenafil use in restrictive cardiomyopathy). Exclusion Criteria: Resistant drop in blood pressure with mean arterial pressure less than 60; Increasing blood pressure needing therapeutic interventions more than predicted in study method.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum bicarbonate concentration. Timepoint: Before start of anesthesia, per hour during surgery, at the end of surgery. Method of measurement: Arterial Blood Gas Analysis.;Serum base deficit. Timepoint: Before start of anesthesia, per hour during surgery, at the end of surgery. Method of measurement: Arterial Blood Gas Analysis.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026